Resistant Potato Starch to Alleviate GWI

Recruiting Phase 2 Interventional Study
Gulf War Illness
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 – 85
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
52 (estimated)
Sponsor
VA Office of Research and Development · Federal
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Gulf War Illness (GWI) affects an estimated 25-32% of the over 700,000 coalition troops deployed to the Persian Gulf as part of the First Gulf War. GWI causes a range of pain, fatigue, gastrointestinal, skin, neurologic, and respiratory symptoms. New treatments to reduce GWI-associated morbidity are critically needed. Research suggests a role for the gastrointestinal microbiome in mediating health…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Ability to provide informed written consent 2. Willing to comply with all study procedures and be available for the duration of the study (including providing stool samples) 3. Meeting the modified Kansas GWI case definition\* with gut symptoms endorsed 4. Deployed to Persian…
Contacts

Nasia Safdar, MD PhD

(608) 280-7007

Nasia.Safdar@va.gov

CONTACT

Julie A Keating, PhD

(608) 256-1901

julie.keating@va.gov

CONTACT